BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2004
View Archived Issues
Eisai assumes distribution responsibilities for Aciphex
Read More
Kyorin Pharmaceutical to tie up with ActivX Bioscience
Read More
BioPort signs contract to supply anthrax vaccine
Read More
Dyax and Baxter to collaborate in MIF antibody research
Read More
Innovative Companies files patent for method to stabilize levothyroxine
Read More
KaloBios and Celscia Therapeutics close merger
Read More
Morphotek and NCI sign agreement to develop antibodies for the treatment of various cancers
Read More
Amgen claims two series of calcium channel modulators for bone and PTH disorders
Read More
JT team presents MTP inhibitors devoid of hepatic side effects
Read More
New etonogestrel esters and their use presented by Akzo Nobel scientists
Read More
Novel factor Xa inhibitors prepared and tested at Boehringer Ingelheim
Read More
New adenosine A3 ligands jointly reported by Solvay and ArQule
Read More
Lilly claims new opioid antagonists with utility in obesity and related disorders
Read More
Novel protein kinase inhibitors for cancer and neurological disorders
Read More
Phase Ib trial evaluates WX-UK1 in head and neck cancer patients
Read More
Phase II trial design agreed for InKine's new generation purgative product
Read More
Phase I/II HGTV43 gene construct study commences
Read More
Pivotal Fibrillex study cleared to continue by DSMB
Read More
Axcan submits sNDA for 1g mesalamine suppository
Read More
Zyprexa approved for maintenance in bipolar disorder treatment
Read More
Remoxy advances into phase I
Read More
New expanded indication for Lamictal
Read More
Chiron HIV vaccine enters phase I trial
Read More
Procleix Ultrio Assay receives European CE Mark
Read More
Phase I inhaled doripenem trial commences enrollment
Read More
Improved survival found with Provenge(R) in patients with advanced prostate cancer
Read More
Significant improvements induced by renzapride in IBS
Read More
Dalbavancin reported more effective than vancomycin against catheter-related bloodstream infections
Read More
Evidence of antifungal activity found for Thymus essential oils
Read More
Topical imiquimod found safe and effective in squamous cell carcinoma
Read More